Orange Medipharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-01-2025
- Paid Up Capital ₹ 2.24 M
as on 12-01-2025
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 12-01-2025
- Revenue -38.68%
(FY 2022)
- Profit 9143.84%
(FY 2022)
- Ebitda 173.16%
(FY 2022)
- Net Worth -14.58%
(FY 2022)
- Total Assets 55.30%
(FY 2022)
About Orange Medipharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.24 M.
The company currently has active open charges totaling ₹4.00 M.
Imran Ansari, Humera Yaseen, and Abdullah Ameri serve as directors at the Company.
- CIN/LLPIN
U24233UP2015PTC074326
- Company No.
074326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Orange Medipharmaceuticals Private Limited offer?
Orange Medipharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Psychotherapeutic Agents, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Pantoprazole Drugs, Common Disease Medicines.
Who are the key members and board of directors at Orange Medipharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Imran Ansari  | Director | 05-Nov-2015 | Current |
| Humera Yaseen | Director | 05-Nov-2015 | Current |
Abdullah Ameri  | Director | 17-May-2017 | Current |
Financial Performance of Orange Medipharmaceuticals.
Orange Medipharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.68% decrease. The company also saw a substantial improvement in profitability, with a 9143.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orange Medipharmaceuticals?
In 2020, Orange Medipharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jun 2021 | ₹4.00 M | Open |
How Many Employees Work at Orange Medipharmaceuticals?
Unlock and access historical data on people associated with Orange Medipharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orange Medipharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orange Medipharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
